Kate Jefferson

Kate Jefferson

Baker & McKenzie


Kate is a partner in Baker McKenzie’s Sydney Office. 

Kate is also Co-Head of the Firm's Australian Healthcare Group and a member of the Firm's Asia Pacific Mergers & Acquisition Steering Committee. 

Kate has over 18 years experience as a corporate lawyer, advising on complex, high profile and cross border merger and acquisitions and capital market transactions with individual deal values up to US$10 billion.

Kate is listed as a recommended lawyer by Asia Pacific Legal 500 that comes in for praise' and is recognised as being ‘commercial and attentive'.

Practice Focus

Kate has a broad corporate practice, with particular focus on healthcare and renewable energy transactions.

Kate's practice includes advising on public company takeovers and schemes of arrangement (including defence strategies and takeover panel proceedings), private company acquisitions and disposals, joint ventures and alliances, equity and debt capital raisings (both domestic and international), carve-outs and reorganisations and ASX Listing Rule requirements (including corporate governance and compliance matters).

Kate is highly experienced in all aspects of corporate legal transactions, and draws on her prior management consulting experience and previous secondment to a leading investment bank to provide clients with commercially pragmatic and astute legal advice.

Representative Legal Matters


  • Advised Takeda on the Australian aspects of its post acquisition integration of Shire Plc (US$60b)

  • Advised Ramsay Health Care Limited on its joint venture with Sime Darby (A$500m)

  • Advised iSOFT Group Limited on its acquisition by Computer Sciences Corporation (CSC) by way of scheme of arrangement (A$434m)

  • Advised Boston Scientific Corporation on a potential acquisition of a 20% stake in a medical technology company (~A$20m)

  • Advised Merck Sharp & Dohme Research gmbh on its investments in Bionomics Limited (a company listed on the ASX)

  • Advised Fresenius Medical Care AG &Co on its 144A offer of US$500m Senior Notes

  • Advised Abbott Laboratories on its proposed disposal of its diagnostic units business (US$8.13b)

Renewable Energy 

  • Ratchaburi on its acquisition of a 70% interest (and the associated shareholder arrangements) in Yandin Wind Farm from Alinta

  • Neoen on the equity financing aspects (including a disposal of a minority interest and the shareholder arrangements) of all three stages of the Hornsdale Wind Farm Project (A$870m)

  • Neoen its acquisition of various wind and solar projects, including Bulgana Wind Farm, DeGrussa Solar Farm and the corporate governance arrangements relevant to the development of the Parkes, Griffith and Dubbo Solar Projects


Professional Associations and Memberships

  • Fellow, Financial Services Institute of Australasia
  • Member, Law Society of New South Wales


  • Federal Court of Australia~Australia (2011)
  • High Court of Australia (2011)
  • New South Wales~Australia (2000)


  • Securities Institute of Australia (Graduate Diploma Applied Finance and Investment)
  • University of Newcastle (LLB, BCom, Dip Legal Practice)
  • University of Sydney (LL.M.)


  • English

Previous Offices

  • New York